Approvals/TGA/PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial

Approved

STANDARD

PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ed4f5c4173f4a209
Product Name: PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial
Artg Id: 237761
Artg Name: PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2016-05-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/69645d6777c0c09b8cc0eb43a5a820cc.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1ba26131b8de404d6095a0b0ffca5fc5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

ed4f5c4173f4a209

Type

Standard